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Abstract
The zebra®sh has long been a favourite model for the study of vertebrate development. Here we provide an overview of the
current state of knowledge and resources for the study of this ®sh, with comments on the future direction of zebra®sh
genomics from Professor Mark Fishman and Dr Stephen Wilson. Copyright # 2000 John Wiley & Sons, Ltd.
Summary
$ 3 cm long, translucent, teleost ®sh with black stripes running along their length.
$ Eggs are fertilized and embryos develop (in 2±4 days) externally.
$ Embryos are clear and easily observed under the microscope.
$ Short generation time (y3 months) is ideal for genetics.
$ Diploid, y1700 Mb genome, as 25 chromosomes.
$ 25 linkage groups with centromeres have been characterized.
$ Radiation Hybrid and genetic maps, YAC and P1 libraries and EST resources available, large-scale mutagenesis project
completed, second round under way.
$ Comparative studies with other ®sh, in particular medaka and puffer®sh, and other vertebrates, mainly with human and
mouse.
Background
Zebra®sh (Danio rerio) are small, y3 cm long. They
are native to streams in India and are commonly
kept as pets. The males are slender and torpedo-
shaped, with black longitudinal stripes and usually
a gold colouration on the belly and ®ns. Females
are fat when laden with eggs and have little, if any,
gold on their undersides.
Zebra®sh are easy to raise, with a short genera-
tion time of 3 months, and the females can lay
hundreds of eggs at weekly intervals. Fertilization is
external, allowing easy access to embryos for
observation and manipulation. Developing embryos
are easily studied under a dissecting microscope
since they are transparent. Zebra®sh embryos
develop rapidly (in 2±4 days), with a beating heart
and visible erythrocytes by 24 h. Another advantage
of studying the zebra®sh is that, in contrast to other
®sh, which can be triploid or tetraploid (which
makes genetic analysis dif®cult), it maintains the
diploid state.
The zebra®sh has been shown to be a useful
model for the development of several complex
tissues such as the kidney (Drummond, 2000), the
olfactory system (Ardouin et al., 2000) and the
visual system (Saszik et al., 2000). In the study
of haematopoiesis, zebra®sh mutants have been
observed to demonstrate strikingly similar pheno-
types to those in human diseases (Amatruda and
Zon, 1999).
Sources
The K12 page: http://www.neuro.uoregon.edu/k12/
zfk12.html
The Zon lab page: http://genetics.med.harvard.
edu/yzonlab/
Yeast
Yeast 2000; 17: 225±231.
Copyright # 2000 John Wiley & Sons, Ltd.The Stainer lab page: http://www.ucsf.edu./
dyrslab/z®sh.html
Tools for study
Despite the lack of a technology for gene knockout
by homologous recombination, zebra®sh research-
ers have amassed huge numbers of mutant lines.
The bulk of these were created in a large-scale
mutagenesis project using the chemical mutagen,
ethylnitrosourea (ENU), followed by screening for
developmental defects (Haffter et al., 1996; Driever
et al., 1996). ENU has the advantage of generating
small mutations (compared with those caused by
irradiation), which often affect only one gene. These
studies revealed mutants defective in the develop-
ment of many organ systems, such as the retina
(Malicki et al., 1996), the inner ear (Whit®eld et al.,
1996) and the cardiovascular system (Stainier et al.,
1996). After exhaustive study of the mutants
produced from these experiments, it became clear
that saturation had not been reached and the
initiation of a second large-scale mutagenesis
screen for zebra®sh, the `Tu Èbingen 2000' screen,
was announced recently. The screen will be under-
taken by Artemis Pharmaceuticals in collaboration
with labs at the Max-Planck-Institutes of Develop-
mental Biology and Immune Biology, the Univer-
sity of Heidelberg, the Howard Hughes Medical
Institute in Boston and University College London
(see this issue, pp. 232±234, for an interview with
Dr Stefan Schulte-Merker of Artemis Pharmaceu-
ticals on the mutagenesis screen).
A zebra®sh radiation hybrid (RH) panel (com-
monly known as the `Goodfellow' panel; Kwok
et al., 1998) was produced. This has been used as
the basis for a map designed to aid the positional
cloning of the genes mutated in the strains from the
mutagenesis screens (Geisler et al., 1999).
The NIH Institute-wide Zebra®sh Genome
Initiative, overseen by the Trans-NIH Zebra®sh
Coordinating Committee, was started in September
1998. A YAC library has been created, which
consists of 17 000 clones, and provides y®ve-fold
coverage of the zebra®sh genome (Zhong et al.,
1998). There is also a P1 library, which consists of
4±5 genome equivalents, with clones having an
average insert size of 115 kb (Amemiya and Zon,
1999). The initiative is also funding the creation of
a 0.5±1.0 cM microsatellite map (Shimoda et al.,
1999), mapping of the `Goodfellow' and `Ekker'
(Hukriede et al., 1999) radiation hybrid panels,
which are to be populated with y10 000 expressed
sequence tags (ESTs), and a meiotic map (Kelly
et al., 2000), which is to include markers in common
with the RH maps. To supply those creating the
maps with markers, there is also funding for the
generation of y100 000 ESTs from oligo-
®ngerprinted cDNA libraries representing several
zebra®sh embryo developmental stages and differ-
ent tissues. Another project in the Genome Initia-
tive is to create deletion mutants of the entire
genome. This uses an approach in which c-irra-
diated sperm are used to fertilize wild-type eggs
(Fritz et al., 1996). DNA from gynogenetic haploid
progeny of females produced from this fertilization
is used as the template in multiplex PCR with
primers for any chosen locus. Females carrying the
required deletion are identi®ed due to failure to
amplify that locus in a fraction of their progeny.
The mutants produced will be placed in the
Zebra®sh Stock Center at the University of
Oregon, Eugene (see Web-based Resources), which
is also supported by the NIH initiative.
Tools available for functional analysis in zebra-
®sh include a selection of ectopic expression vectors
(Hyatt and Ekker, 1999), with the option of having
the gene of interest under the control of tissue
speci®c or inducible promoters (Lekven et al.,
2000). One particular example, which allows
targeted gene expression in the zebra®sh, is called
Gal4-UAS (Scheer and Campos-Ortega. 1999). This
system involves two vectors, which are used to
create separate transgenic zebra®sh lines. The ®rst
carries the yeast Gal4 transcriptional activator,
under the control of a given promoter; the second
carries the gene of interest fused to the Gal4 DNA-
binding motif. The zebra®sh are then crossed to
achieve spatial transcription of the chosen gene.
Being transparent, zebra®sh are ideal for expression
pattern monitoring using lacZ or GFP fusion
constructs. Alternative overexpression systems can
use RNA or DNA injection (Krauss et al., 1993;
Linney et al., 1999) and even large clones such as
BACs have been used to rescue mutant phenotypes
(Yan et al., 1998). This type of approach is crucial
in identifying the gene in a chosen mutant that is
responsible for the observed phenotype.
A recent addition to the battery of techniques for
knocking out gene function in zebra®sh is RNAi.
This strategy has been used in Caenorhabditis
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shown to work in zebra®sh (Li et al., 2000;
Wargelius et al., 2000). If this can be shown to
work reliably, it could open an exciting new avenue
for zebra®sh genomics, in which a null phenotype
can be achieved for a chosen gene of interest.
Another similar approach is to block gene expres-
sion using morpholino antisense oligonucleotides.
These modi®ed oligonucleotides form more stable
triple-helices with DNA than normal oligonucleo-
tides (Lacroix et al., 2000). As yet, though, no in-
depth study of this method in zebra®sh has been
published.
Current Status of Genome Knowledge
The zebra®sh genome is y1700 Mb in size, as 25
chromosomes. The basis for all of the maps of the
genome consists of 25 linkage groups on which the
25 centromeres have been placed (Johnson et al.,
1996). There are radiation hybrid (RH) and meiotic
maps of the genome onto which CA repeat
markers, mutations and ESTs have been placed.
There are currently 3000 microsatellites and over
1000 genes and ESTs on the meiotic map (Kelly
et al., 2000), and 3000 ESTs have been placed on
the `Goodfellow' RH panel, 1000 of which have
also been mapped on the `Ekker' RH panel (Zon
Lab web page).
Comparison of the zebra®sh gene map to a
selection of mammalian genomes (Postlethwait
et al., 1998) yielded signi®cant evidence of synteny.
A comparison of the zebra®sh HOX clusters to
those of other vertebrates (Amores et al., 1998)
provided evidence for a genome duplication event,
which is thought to have occurred after the
divergence of ray-®nned and lobe-®nned ®shes but
before the teleost radiation. Further comparison of
the seven zebra®sh HOX complexes with the four in
Fugu con®rmed gene loss as a dominant feature of
the evolution of tetrapod and teleost HOX clusters
(Aparicio, 2000).
Future aims
Professor Mark Fishman is the director of the
Cardiovascular Research Center at the Massachu-
setts General Hospital. His group is applying a
genetic approach to the study of the earliest steps of
development of cardiovascular form and function in
zebra®sh.
He feels that the key to the zebra®sh is the
genetic screen. He did the ®rst large-scale screens
in collaboration with Wolfgang Driever (and
in parallel with Professor Christiane Nu Èsslein-
Volhard's group) and they were remarkably infor-
mative. They were astounded by how modular the
genetic disruptions were, i.e. that single gene
mutations deleted or perturbed single units of
form (e.g. removing a chamber or a valve of the
heart). This demonstrated the unitary logic of organ
assembly. The next step will be to clone these genes,
which will provide the necessary handles on
molecular pathways for these units, such as the
`ventricular pathway'.
A second consideration in his work is that organs
are functioning devices, and embryonic survival
depends upon certain of them, such as the cardio-
vascular system, kicking in from day one. The
zebra®sh is quite viable and vigorous without a
functioning cardiovascular system because it sur-
vives by diffusion from the water during the ®rst
few days. This is in distinction to the mouse, in
which secondary degeneration begins immediately
upon cessation of cardiac function. Thus, for the
®rst time, it is possible to analyse the genes that
drive function in the embryo. So, he can now see a
way to answer questions like: `What makes the ®rst
heart beat?'; `How does contraction drive cellular
development?'; and `Does blood ¯ow cause or
modify vessel formation?'. He also sees similar
questions being answered with regard to the onset
of function for renal, gut and other organ systems.
The phenotypes of many of these mutations provide
eerily accurate phenotypic models of complex
human diseases, for which we have few candidate
genes. In this regard, he feels that the zebra®sh will
be the salvation of physiology and the way to
search the human genome project for real gold.
Professor Fishman's view is that the main value
of mapping and sequencing of the genome is that it
will expedite mutation cloning. However, he notes
that zebra®sh genome comparisons with other
species will provide good starting points for analysis
of regulatory elements, and insight into how their
divergence might cause large-scale structural
changes during evolution.
He anticipates that new screens will be applied to
the understanding of organ formation and physiol-
ogy, evolutionary biology and other areas. Beha-
viour, learning, and memory are already the focus
of some early phase studies and suppressor and
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tions. In addition, the relatively ready penetrance of
many chemicals into the viable embryo makes them
targets for chemical screens, relevant to drug
discovery and toxicology.
Dr Stephen Wilson is a Wellcome Senior
Research Fellow and Reader at the Department of
Anatomy and Developmental Biology at University
College London. His group is studying the mechan-
isms underlying the patterning of cells and tissues in
the embryonic zebra®sh, with a focus on the
embryonic development of the forebrain.
He feels that genome sequencing is a major
priority for the community for several reasons, but
perhaps primarily to facilitate the rapid cloning of
genes affected by mutations isolated in a wide
variety of genetic screens, using a candidate gene
approach.
He sees full-length cDNA sequencing as an
essential parallel project to genome sequencing to
facilitate the identi®cation of coding sequences
within the genome. This will be essential to aid in
the cloning of mutations and for functional analysis
of the genome, as a wide variety of mis-expression
strategies now exist in zebra®sh, provided that one
has access to full-length coding sequence. Genera-
tion of new libraries, from wild-type and transgenic
lines, is likely to be essential for this project. As
further cDNA resources become available, such as
Unigene sets, then the generation of extremely well-
characterized arrayed libraries will be possible.
He also feels that zebra®sh are perhaps the most
suitable vertebrate model system (owing to their
transparency and availability in huge numbers) in
which to perform large-scale expression pro®ling
analysis of genes by in situ hybridization. Using
whole embryos at a variety of developmental stages,
it is possible to rapidly, accurately and economically
determine sites and times of expression of thou-
sands of genes during embryonic and larval devel-
opment. This type of analysis has been initiated in
several groups, but Stephen's feeling is that it needs
to be expanded and funded on a larger scale.
From these large-scale expression pro®ling pro-
jects, large numbers of genes with highly speci®c
expression patterns will be isolated. In his opinion it
will be important to establish selected transgenic
GFP lines that label speci®c cell populations in
the ®sh by using regulatory sequences that control
the expression of these genes. Such lines will be
essential for detailed phenotypic analysis (by cross-
ing them to mutant lines), for detailed screening
procedures and for the isolation of cell type-speci®c
RNA populations that may be underrepresented in
more general libraries.
Stephen points out that if antisense morpholinos
turn out to reliably inhibit gene function, then as
soon as full-length cDNA sequences are obtained,
large-scale `knock-out' analysis becomes possible.
This would certainly not replace true genetic
approaches, but may be an initial ®rst indicator of
gene function. He also notes that existing screens
have isolated only a fraction of the mutant lines
that can be obtained and so it is clear that further
directed screens are essential. These should include
screens by morphology, by gene and protein
expression (using wild-type and transgenic-GFP
lines), by behaviour, physiology and as many other
criteria as investigators can establish.
In addition, Stephen asserts that more knowledge
of anatomy, physiology, cell biology and behaviour
of developing and adult ®sh, organized and pre-
sented on the web via ZFIN (see Web-based
Resources), will be required to fully make sense of
gene function analysis studies.
Web-based resources
General information on zebra®sh
The Zebra®sh Information Network (ZFIN)
http://z®sh.uoregon.edu/
This page contains a vast array of information on
zebra®sh anatomy, genetic strains, maps, genes,
ESTs and probes. There are news pages, a protocol
book, a link to the zebra®sh newsgroup, laboratory
and researcher lists and information about the stock
centre.
Mapping and sequencing projects
The Zebra®sh webserver at the Cardiovascular
Research Centre of Massachusetts General Hospital
http://zebra®sh.mgh.harvard.edu/
This site provides access to zebra®sh genetic maps,
made using microsatellites, as a searchable on-line
database and ®gures of the maps of each of the 25
linkage groups. There is also an atlas of zebra®sh
anatomy and information on a YAC library created
by the group.
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http://z®sh.wustl.edu/
The group are developing ESTs from y50 000
zebra®sh cDNAs, derived from libraries produced
from a selection of sources, such as adult brain,
kidney and liver. The cDNA clones are available
from Incyte (http://www.genomesystems.com) and
from the Resource Centre/Primary Database
(RZPD) section of the German Human Genome
Project (http://www.rzpd.de). The project also
involves mapping of the ESTs onto a radiation
hybrid (RH) map.
The Children's Hospital Zebra®sh Genome Initiative
http://134.174.23.167/zonrhmapper/Default.
htm#index
This page provides maps and a service in which the
group will use your sequence or your primers
to place a marker of your choice onto the map.
They also provide the protocols they are using so
that users can map a marker onto the panel
themselves.
The Dawid Laboratory ± Zebra®sh Radiation Hybrid
Mapping
http://dir.nichd.nih.gov/lmg/lmgdevb.htm
This group provides access to their radiation hybrid
panel so that users can place a marker of interest
onto the map. There are images of the maps of all
25 linkage groups and mapping data from a cDNA
expression screen.
The Trans-NIH Zebra®sh Initiative
http://www.nih.gov/science/models/zebra®sh/
This page contains information on funding oppor-
tunities, reports of previous meetings relating to the
initiative, future meetings and courses and a list of
zebra®sh links.
Gene indices
The TIGR Gene Index for Zebra®sh
http://www.tigr.org/tdb/zgi/
This is a database of zebra®sh expressed sequences
classi®ed into three categories: ESTs (partial, single-
pass sequences from either end of cDNA clones);
CT's (tentative consensuses, built from overlapping
EST sequences); and ETs (mature transcripts, with
untranslated regions where possible). The database
can be searched with a gene name or identi®er, by
tissue or library identi®er, or by using a BLAST
search with a sequence of interest.
The NCBI Unigene Zebra®sh Sequences Collection
http://www.ncbi.nlm.nih.gov/UniGene/Dr.Home.html
A non-redundant set of zebra®sh genes generated
from known genes and automated clustering of the
EST data. These can be searched by keyword or
cDNA library type.
Zebra®sh stock centres
The Zebra®sh International Resource Center
http://z®sh.uoregon.edu/zf_info/stckctr/stckctr.html
The center has a collection of wild-type, mutant and
transgene-carrying ®sh and frozen sperm. The
center provides information and advice on keeping
zebra®sh and researchers can visit the center to
learn techniques or screen the collection for mutants
of interest.
Comparative and functional genomics
projects
The Stanford Zebra®sh Genome Project
http://zebra®sh.stanford.edu/genome/Frontpage.html
This page has genetic maps of zebra®sh and the
results of a comparison made with the human
genome. There are also pages detailing the group's
efforts towards the generation of new markers for
use in the maps.
The Zebra®sh Deletion Project
http://www.ciwemb.edu/labs/halpern/zdp.html
Although these pages are still under construction,
there is a tool available to look for deletions
available in each linkage group and contact details
for members of the group, to arrange to obtain
mutants from their stocks.
The UCL Zebra®sh Research Group
http://www.ucl.ac.uk/zebra®sh-group/
The group is involved in screening mutants from
both of the Tu Èbingen zebra®sh mutagenesis pro-
jects. They are also undertaking a smaller-scale
mutagenesis screen of their own. There is also a
small stock centre, with just over 100 lines, which
are made available to the community.
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General
Detrich HW, Zon LI, Wester®eld M (eds). 1998.
The Zebra®sh, vol 1: Biology. Methods in Cell
Biology Series. Academic Press: New York.
Detrich HW, Zon LI, Wester®eld M (eds). 1998.
The Zebra®sh, vol 2: Genetics and Genomics.
Methods in Cell Biology Series. Academic Press:
New York.
Techniques
Guille M (ed.). 1999. Molecular Methods in
Developmental Biology: Xenopus and Zebra®sh.
Methods in Molecular Biology, vol 127.
Humana Press: Totowa, NJ.
Wester®eld M. 1994. The Zebra®sh Book: A Guide
for the Laboratory Use of Zebra®sh (Danio
rerio). Institute of Neuroscience: University of
Oregon.
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Copyright # 2000 John Wiley & Sons, Ltd. Yeast 2000; 17: 225±231.Comparative and Functional Genomics is a cross-organism journal, publishing studies on complex and
model organisms. The `Featured Organism' article aims to present an overview of an organism, primarily
for those working on other systems. It provides background information on the organism itself and on
genomics studies currently in progress. It also gives a list of web sites containing further information and a
summary of the status of the study of the genome. These sections are a personal critical analysis of the
current studies of the particular organism. The `Future Aims' section is intended to be of interest to readers
who work on the chosen organism and those who study other systems, and the opinions expressed therein
are those of the named contributors.
Many thanks to Professor Philip Ingham (Section Editor ± zebra®sh) for his critical appraisal of this article
and to Professor Mark Fishman and Dr Stephen Wilson for sharing their thoughts on the future of
zebra®sh genomics research with me.
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